Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Diabetic Medicine

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1464-5491.2001.00445.xPMID 11318838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy.

  2009cited by this paper
• Plasma Homocysteine and Cardiovascular Disease

  2000cited by this paper
• Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk.

  2000cited by this paper
• Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.

  1999cited by this paper
• The Increase of Plasma Homocysteine Concentrations with Age Is Partly due to the Deterioration of Renal Function as Determined by Plasma Cystatin C

  1998cited by this paper
• Correction of neurovascular deficits in diabetic rats by beta2-adrenoceptor agonist and alpha1-adrenoceptor antagonist treatment: interactions with the nitric oxide system.

  1998cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study.

  1998cited by this paper
• Oxidative Stress in Diabetic Macrovascular Disease: Does Homocysteine Play a Role?

  1997cited by this paper
• Defective homocysteine metabolism as a risk factor for diabetic retinopathy.

  1997cited by this paper
• Hyperhomocyst(e)inemia and Endothelial Dysfunction in IDDM

  1997cited by this paper
• Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study

  1997cited by this paper
• Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy

  1997cited by this paper
• The JEVIN trial: A population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990

  1997cited by this paper
• Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.

  1997cited by this paper
• Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.

  1997cited by this paper
• Diabetes Increases Sciatic Nerve Susceptibility to Endothelin-Induced Ischemia

  1996cited by this paper
• Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease.

  1996cited by this paper
• Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians.

  1996cited by this paper
• Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.

  1996cited by this paper
• The biochemical basis of the neuropathy in cobalamin deficiency.

  1995cited by this paper
• Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.

  1995cited by this paper
• Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine.

  1995cited by this paper
• Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

  1995cited by this paper
• Homocysteine-Induced Oxidative Damage: Mechanisms and Possible Roles in Neurodegenerative and Atherogenic Processes

  1995cited by this paper
• Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjects

  1994cited by this paper
• A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy

  1994cited by this paper
• Association between “diabetic thick skin syndrome” and neurological disorders in diabetes mellitus

  1994cited by this paper
• The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications.

  1994cited by this paper
• Literature Reviews: Endocrinology

  1994cited by this paper
• Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus.

  1994cited by this paper
• Plasma homocysteine in renal failure.

  1993cited by this paper
• Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.

  1993cited by this paper
• A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

  1993cited by this paper
• Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.

  1993cited by this paper
• Assessment of Cardiovascular Autonomic Function: Age‐related Normal Ranges and Reproducibility of Spectral Analysis, Vector Analysis, and Standard Tests of Heart Rate Variation and Blood Pressure Responses

  1992cited by this paper
• High Performance Liquid Chromatography Method for Rapid and Accurate Determination of Homocysteine in Plasma and Serum

  1991cited by this paper
• Plasma homocyst(e)ine levels in men with premature coronary artery disease.

  1990cited by this paper
• Interpretation of coronary angiograms.

  1990cited by this paper
• Immunology of diabetic and polyglandular neuropathy.

  1990cited by this paper
• [Recent advances in the pathogenesis of diabetic neuropathy].

  1989cited by this paper
• Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing

  1989cited by this paper
• Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology.

  1988cited by this paper
• Methylation Deficiency Causes Vitamin B12‐Associated Neuropathy in the Pig

  1988cited by this paper
• Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy

  1988cited by this paper
• Pathogenesis and prevention of diabetic neuropathy.

  1988cited by this paper
• Factors in Development of Diabetic Neuropathy: Baseline Analysis of Neuropathy in Feasibility Phase of Diabetes Control and Complications Trial (DCCT)

  1988cited by this paper
• Recent advances in the pathogenesis of diabetic neuropathy. Clues from human diabetic neuropathy

  1987cited by this paper
• Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.

  1986cited by this paper
• Capillary number and percentage closed in human diabetic sural nerve.

  1985cited by this paper
• Homocysteine theory of arteriosclerosis: development and current status

  1983cited by this paper
• Endothelial cell dysfunction in homocystinuria

  1983cited by this paper
• Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury.

  1980cited by this paper
• Electron microscopical studies of vessels in diabetic peripheral neuropathy.

  1980cited by this paper
• Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973

  1978cited by this paper
• Labile methyl balances for normal humans on various dietary regimens.

  1975cited by this paper

• Dose dependent relationship of metformin use and diabetic peripheral neuropathy risk in patients with type 2 diabetes mellitus

  2025cites this paper
• Association of interleukin 4 and MTHFR gene polymorphisms with distal symmetrical polyneuropathy in young diabetics

  2024cites this paper
• Dual mapping of MTHFR C677T (A1298C) and BDNF G196A (Val66Met) polymorphisms in patients with diabetic peripheral neuropathy.

  2023cites this paper
• Association between Hyperhomocysteinemia and Microangiopathic Complications (Neuropathy and Nephropathy) in Subjects with Type 1 and Type 2 Diabetes

  2023cites this paper
• A one-step aptasensor for ultrasensitive detection of lung cancer marker homocysteine based on multifunctional carbon nanotubes by square-wave voltammetry.

  2023cites this paper
• Detecting homocysteine in cardiovascular disease using aptasensors: A Review

  2023cites this paper
• Fiber selectivity of peripheral neuropathy in patients with Parkinson's disease

  2022cites this paper
• Relationship of Homocysteine With Gender, Blood Pressure, Body Mass Index, Hemoglobin A1c, and the Duration of Diabetes Mellitus Type 2

  2021cites this paper
• Involvements of Hyperhomocysteinemia in Neurological Disorders

  2021cites this paper
• Association between neuropathy and B‐vitamins: A systematic review and meta‐analysis

  2021cites this paper
• Genetic Risk Factors in the Development of Hyperhomocysteinemia

  2021cites this paper
• Influence of purinergic signaling on glucose transporters: a possible mechanism against insulin resistance?

  2020cites this paper
• Homocysteine and Peripheral Neuropathy

  2020cites this paper
• A potential role for T-type calcium channels in homocysteinemia-induced peripheral neuropathy.

  2019cites this paper
• Genetics of diabetic neuropathy: Systematic review, meta‐analysis and trial sequential analysis

  2019cites this paper
• Chapter 13 – Peripheral Neuropathy

  2018cites this paper
• A review on association of serum homocysteine in diabetic neuropathy

  2018cites this paper
• An update on vitamin D and B deficiency in the pathogenesis and treatment of diabetic neuropathy: a narrative review

  2018cites this paper
• Association between MTHFR variant and diabetic neuropathy

  2018cites this paper
• Le diabète, facteur de dénutrition et de carences en micronutriments ?

  2017cites this paper
• Serum folate, vitamin B12 levels and diabetic peripheral neuropathy in type 2 diabetes: A meta-analysis.

  2017cites this paper
• Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy

  2017cites this paper
• Синергидные нейропротекторные эффекты тиамина, пиридоксина и цианокобаламина в рамках протеома человека

  2017cites this paper
• Effects of Common Polymorphisms in the MTHFR and ACE Genes on Diabetic Peripheral Neuropathy Progression: a Meta-Analysis

  2017cites this paper
• Clinical Manifestations of Isolated Elevated Homocysteine-Induced Peripheral Neuropathy in Adults

  2016cites this paper
• The Relation between Plasma Homocysteine Levels and Diabetic Foot Ulcer in Egyptian Patients with Type 2 Diabetes

  2016cites this paper
• Correlation between elevated serum homocysteine level and the development of diabetic peripheral neuropathy : a comparative study and meta-analysis

  2016cites this paper
• Recent advances in exploring the genetic susceptibility to diabetic neuropathy.

  2016cites this paper
• Dietary diversity no longer offsets the mortality risk of hyperhomocysteinaemia in older adults with diabetes: a prospective cohort study.

  2016cites this paper
• A high thyroid stimulating hormone level is associated with diabetic peripheral neuropathy in type 2 diabetes patients.

  2016cites this paper
• [Deficiency of Magnesium and Pyridoxine as a Risk Factors for Coronary Heart Disease].

  2016cites this paper
• Serum homocysteine levels and diabetic neuropathy in patients with type 2 diabetes mellitus : a systematic review and meta-analysis

  2016influential citation
• Neurophysiologic Features of Carpal Tunnel Syndrome in Adults with an Isolated Elevated Plasma Level of Homocysteine

  2015cites this paper
• Lecithin: Cholesterol Acyltransferase Activity and Homocysteine Levels are Better Associated with Lipid Profile Indices Compared to Glycemic Control Indices in Patients with Diabetes Mellitus

  2015cites this paper
• RETRACTED ARTICLE: Effects of Common Polymorphisms in the MTHFR and ACE Genes on Diabetic Peripheral Neuropathy Progression: a Meta-Analysis

  2015cites this paper
• Why You Should Consider The Use Of Supplements In The Management Of Diabetic Neuropathy | Podiatry Today

  2015cites this paper
• Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin

  2015cites this paper
• Elevated serum homocysteine level in the development of diabetic peripheral neuropathy.

  2015cites this paper
• A Cross Sectional Study To Determine The Prevalence Of Autonomic Dysfunction In Type Ii Diabetic Mellitus Individuals In Rural Population Residing At Three Primary Health Center Phc Areas Associated To Jawaharlal Nehru Medical College Belgaum

  2014cites this paper
• Atherogenic Activity of Hypercholesterolemia and Hyperhomocysteinemia in Complicated Type 2 Diabetes Mellitus.

  2014cites this paper
• Erratum to “Addition of Metanx in Pregabalin Partial Responders for Painful Diabetic Neuropathy”

  2014cites this paper
• Nutritional management of diabetic nephropathy

  2014cites this paper
• Elevated plasma level of homocysteine is an independent risk factor for peripheral neuropathy.

  2014influential citation
• Hyperhomocysteinemia and Neurologic Disorders: a Review

  2014cites this paper
• Echocardiographic assessment of hypertensive patients with or without hyperhomocysteinemia

  2014cites this paper
• Plasma Homocysteine level and its clinical correlation with type 2 diabetes mellitus and its complications

  2014cites this paper
• The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy

  2014cites this paper
• Association of MTHFR gene C677T mutation with diabetic peripheral neuropathy and diabetic retinopathy

  2013cites this paper
• Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.

  2013cites this paper
• Nutritional Approaches to Treat Diabetic Neuropathy: A Systematic Review

  2013cites this paper
• Association between Hyperhomocysteinemia and Diabetic Retinopathy

  2013cites this paper
• Addition of Metanx in pregabalin partial responders for painful diabetic neuropathy

  2013cites this paper
• Distální symetrická diabetická polyneuropatie

  2013cites this paper
• [Correlation between plasma concentrations of homocysteine and diabetic polyneuropathy evaluated with the Semmes-Weinstein monofilament test in patients with type 2 diabetes mellitus].

  2013cites this paper
• Plasma total homocysteine is not associated with peripheral neuropathy in a groups Bangladeshi type 2 diabetic subjects

  2012cites this paper
• Could the open door crack on perioperative visual loss be even bigger?

  2012cites this paper
• Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects

  2012cites this paper
• Are vitamin D and B deficiency relevant to the pathogenesis and treatment of diabetic neuropathy

  2012cites this paper
• Is the C677T polymorphism in methylenetetrahydrofolate reductase gene or plasma homocysteine a risk factor for diabetic peripheral neuropathy in Chinese individuals?

  2012cites this paper
• Association of MTHFR and PPARγ2 gene polymorphisms in relation to type 2 diabetes mellitus cases among north Indian population.

  2012cites this paper
• Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis.

  2012cites this paper
• Association of homocysteine with peripheral neuropathy in Chinese patients with type 2 diabetes.

  2011influential citation
• Altered nerve excitability in subclinical/early diabetic neuropathy: evidence for early neurovascular process in diabetes mellitus?

  2011cites this paper
• Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease

  2011cites this paper
• Diabetes and Alpha Lipoic Acid

  2011cites this paper
• Management of diabetic small-fiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate.

  2011cites this paper
• Estimation of Serum Homocysteine Level in Patients with Type 2 Diabetic Neuropathy

  2010cites this paper
• Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus

  2010cites this paper
• Vitamin B12 may be more effective than nortriptyline in improving painful diabetic neuropathy

  2009cites this paper
• Drug-Nutrient Interactions and Immune Function

  2009cites this paper
• Remittive therapy in the management of symptomatic and nonsymptomatic diabetic neuropathy.

  2009cites this paper
• Pain associated with diabetic peripheral neuropathy: a review of available treatments.

  2008cites this paper
• Two Cardiovascular Risk Factors in One? Homocysteine and Its Relation to Glomerular Filtration Rate

  2008cites this paper
• Mecobalamin

  2008cites this paper
• Prevalence and Risk Factors for Neuropathy in a Canadian First Nation Community

  2008cites this paper
• Nitric oxide and peroxynitrite signalling triggers homocysteine-mediated apoptosis in trigeminal sensory neurons in vitro.

  2008cites this paper
• Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment.

  2007cites this paper
• Overview on Pathophysiology and Newer Approaches to Treatment of Peripheral Neuropathies

  2007cites this paper
• Peripheral neuropathy: pathogenic mechanisms and alternative therapies.

  2006cites this paper
• New and emerging treatment options for neuropathic pain.

  2006cites this paper
• Adjuvant strategies for prevention of glomerulosclerosis.

  2006cites this paper
• Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients

  2006influential citation
• Conservative treatment of peripheral neuropathy and neuropathic pain.

  2006cites this paper
• Homocysteine and vascular disease in diabetes: a double hit?

  2005cites this paper
• Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: the Hoorn Study

  2005cites this paper
• Homocysteine concentrations in patients with diabetes mellitus – relationship to microvascular and macrovascular disease

  2005cites this paper
• Methylene tetrahydrofolate reductase C677T mutation and left ventricular hypertrophy in Turkish patients with type II diabetes mellitus.

  2004cites this paper
• Handbook of Drug-Nutrient Interactions

  2004cites this paper
• Homocisteína en el paciente con diabetes mellitus

  2004cites this paper
• Neurotoxicity of Folic Acid

  2004cites this paper
• [Homocysteine in patients with diabetes mellitus].

  2004cites this paper
• Diet and Human Immune Function

  2004cites this paper
• Use of Drugs that Affect Nutrition and Immune Function

  2004cites this paper
• Biochemistry and Clinical Role of Human Cystatin C

  2004cites this paper
• Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy

  2004cites this paper
• Epidemiology of Homocysteine as a Risk Factor in Diabetes

  2003cites this paper
• Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes.

  2003cites this paper
• Diabetes Mellitus and Hyperhomocysteinemia

  2002cites this paper
• Cystatin C

  2002cites this paper
• [Clinical relevance of homocysteine monitoring in the diabetic patient].

  2002cites this paper